What is more, in TME, the pro‐tumoral activity of IL‐1α is also extended to its key role in favoring immunotherapy resistance and suppression of anti‐tumor immunity via polymorphonuclear myeloid‐derived suppressor cells (PMN‐MDSCs).6 Here, IL1A is linked to neoplasm.